Nifty
Sensex
:
:
16183.75
54238.92
-30.95 (-0.19%)
-49.69 (-0.09%)

Pharmaceuticals & Drugs - Domestic

Rating :
68/99

BSE: 509079 | NSE: GUFICBIO

228.90
23-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  240.00
  •  241.00
  •  227.55
  •  243.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  166501
  •  386.61
  •  290.00
  •  171.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,219.06
  • 23.15
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,261.23
  • 0.04%
  • 8.25

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.48%
  • 0.90%
  • 17.65%
  • FII
  • DII
  • Others
  • 1.51%
  • 1.03%
  • 3.43%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.29
  • 14.71
  • 11.61

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 27.59
  • 29.60
  • 12.78

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 39.99
  • 37.44
  • 26.33

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.69
  • 32.84
  • 26.43

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.31
  • 8.31
  • 8.31

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.19
  • 18.11
  • 15.67

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • Gufic Biosciences - Quarterly Results
    20th May 2022, 19:16 PM

    Read More
  • Gufic Biosciences to manufacture, sell, distribute Isavuconazonium Sulfate API & finished formulation Isavuconazole
    11th Apr 2022, 17:43 PM

    Isavuconazole for Injection 200 mg/vial is indicated for the treatment of patients having 18 years of age and older for the treatment of Invasive Aspergillosis and Invasive Mucormycosis

    Read More
  • Gufic Biosciences gets DCGI nod for Thymosin Alpha-1
    5th Apr 2022, 16:48 PM

    Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 Clinical trial in adult patients with moderate-to-severe Covid-19

    Read More
  • Gufic Biosciences incorporates wholly owned subsidiary company
    17th Mar 2022, 11:20 AM

    Gufic UK is incorporated with the object to expand its pharmaceutical business in United Kingdom

    Read More
  • Gufic Biosciences enters into research and collaboration agreement with Selvax
    10th Mar 2022, 09:52 AM

    Selvax considers Gufic as an ideal collaboration partner on account of Gufic's long track record of innovation and new drug development

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.